Soleus Capital Amends IRADIMED Stake, Signals Continued Interest

TL;DR

**Soleus Capital is still in on IRADIMED, filing an update to their stake.**

AI Summary

Soleus Capital Master Fund, L.P. filed an amended Schedule 13G/A on February 2, 2024, indicating their ownership of IRADIMED CORPORATION (IRMD) common stock as of December 31, 2023. This amendment, their second, updates their previous filing but does not disclose specific share counts or percentage ownership in the provided text. This matters to investors because it signals continued institutional interest from Soleus Capital in IRADIMED, which can be a positive indicator of confidence in the company's future prospects.

Why It Matters

This filing shows that Soleus Capital Master Fund, L.P. maintains a significant, though unspecified, stake in IRADIMED CORP, suggesting their ongoing belief in the company's value.

Risk Assessment

Risk Level: low — This is a routine amendment filing by an institutional investor and does not inherently present significant new risks.

Analyst Insight

Investors should note Soleus Capital's continued interest in IRADIMED, but without specific share count details in this excerpt, further investigation into their exact holdings and IRADIMED's fundamentals is warranted before making investment decisions.

Key Players & Entities

• Soleus Capital Master Fund, L.P. (company) — the reporting person filing the SC 13G/A
• IRADIMED CORPORATION (company) — the issuer of the common stock
• Guy Levy (person) — a group member associated with Soleus Capital
• Soleus Capital Group, LLC (company) — a group member associated with Soleus Capital
• Soleus Capital, LLC (company) — a group member associated with Soleus Capital

Forward-Looking Statements

• Soleus Capital Master Fund, L.P. will maintain a significant stake in IRADIMED CORPORATION for the foreseeable future. (Soleus Capital Master Fund, L.P.) — medium confidence, target: December 31, 2024

FAQ

Filing Documents

• ea192413-13ga2soleus_iradi.htm (SC 13G/A) — 159KB
• 0001213900-24-009370.txt ( ) — 161KB

Ownership

Item 4. Ownership. Reference is made to Items 5 – 11 on the preceding pages of this Schedule 13G. Soleus Capital Master Fund, L.P. (“Master Fund”) holds, as of the close of business on December 31, 2023, an aggregate of 641,706 shares of the common stock of the Issuer, and Mr. Guy Levy holds, as of the close of business on December 31, 2023, 1,500 shares of the common stock of the Issuer, for aggregate holdings by the Reporting Persons of 643,206 shares. As the general partner of Master Fund, Soleus Capital, LLC may be deemed to have shared power to vote or to direct the vote and to dispose or to direct the disposition of the shares held by Master Fund. As the sole managing member of Soleus Capital, Soleus Capital Group, LLC may be deemed to have shared power to vote or to direct the vote and to dispose or to direct the disposition of the shares held by Master Fund. As the sole managing member of Soleus Capital Group, LLC, Mr. Guy Levy may be deemed to have shared power to vote or direct the vote and to dispose or to direct the disposition of the Shares held by Master Fund. Neither the filing of this Schedule 13G nor any of its contents shall be deemed to constitute an admission that Mr. Levy, Soleus Capital, LLC or Soleus Capital Group, LLC is the beneficial owner of the shares of the common stock of the Issuer referred to herein for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, or for any other purpose, and such beneficial ownership is expressly disclaimed, except to the extent of their respective pecuniary interests therein.

Ownership of Five Percent or Less of a Class

Item 5. Ownership of Five Percent or Less of a Class Not applicable. 7

Ownership of More than Five Percent on Behalf of Another Person

Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company Not applicable.

Identification and Classification of Members of the Group

Item 8. Identification and Classification of Members of the Group Not applicable.

Notice of Dissolution of Group

Item 9. Notice of Dissolution of Group Not applicable.

Certification

Item 10. Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose, or with the effect, of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. 8 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct. Date: February 2, 2024 Soleus Capital Master Fund, L.P. By: Soleus Capital, LLC, its General Partner By: Soleus Capital Group, LLC, its Managing Manager By: /s/ Guy Levy Name: Guy Levy Title: Managing Member Date: February 2, 2024 Soleus Capital, LLC By: Soleus Capital Group, LLC, its Managing Manager By: /s/ Guy Levy Name: Guy Levy Title: Managing Member Date: February 2, 2024 Soleus Capital Group, LLC By: /s/ Guy Levy Name: Guy Levy Title: Managing Member Date: February 2, 2024 /s/ Guy Levy Name: Guy Levy Footnotes: Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001) 9

View Full Filing

View this SC 13G/A filing on SEC EDGAR